Optimal Dose of Vitamin D in COVID-19: Survey of 2338 Indian Doctors brings in a First time consensus
New Delhi: Vitamin D levels of 40 ng/mL and above confer a better immune-protective response to several infections, including COVID-19, a pan India Survey of 2,338 pan-India Doctors has brought to consensus for the very first time.
For the first time in India, Rastogi et al. issued a consensus statement to explain the therapeutic role of Vitamin D based on the systematic questionnaire-based and Knowledge, Attitudes and Practices (KAP) survey among 2,338 pan-India health care professionals (HCPs).
The observational study has been published in the Asian Journal of Diabetology issue.
Currently, there is a lack of consensus on the use of vitamin D for immune protection and the dose of vitamin D for either prevention or treatment of COVID-19. The goal of the accompanying consensus statement also includes arriving at common dosage and duration of vitamin D for immune modulatory function.
The expert panel highlights the immune-boosting potential of vitamin D and its potential role in decreasing morbidity, mortality, and ICU admission, especially in COVID-19 patients, through regulating cytokine storms via immunomodulatory actions.
The statement offered evidence of vitamin D deficiency in the Indian general population despite the increasing awareness of the role of vitamin D in bone health, cardiovascular metabolism, and immunity. About 30% of HCPs participated in the survey reported that 60-80% of the patients have vitamin D deficiency, while 32% of HCPs in the survey said that 40-60% of the patients have vitamin D deficiency.
With this backed evidence, the consensus statement agreed on a common optimal vitamin D dose at 40 ng/mL and above for maintaining good immunity.
Furtherly, the statement recommends vitamin D supplementation of 60,000 IU/week for 2 to 6 months and 2,000 IU/day for 3 to 6 months in vitamin D-deficient patients for optimal response to therapy in COVID-19 patients.
Reference:
ASHU RASTOGI, JAYA PRAKASH SAHOO et al. Asian Journal of Diabetology, Vol. 23, No. 2, April-June 2022
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.